Contribution of nitric oxide to β2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature

British Journal of Clinical Pharmacology

Volumn 47, Issue 2, 1999, Pages 173-177

  Majmudar, N G ^a   Anumba, D ^a   Robson, S C ^a   Ford, G A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

adrenoceptor; Forearm; GTN; Nitric oxide; Ritodrine; Serotonin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; RITODRINE; SEROTONIN; VASODILATOR AGENT;

ADULT; ARTERY DILATATION; ARTICLE; FEMALE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ARTERIES; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; NITRIC OXIDE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; RECEPTORS, ADRENERGIC, BETA-2; RITODRINE; SEROTONIN; VASODILATION;

EID: 0032988366     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00880.x     Document Type: Article

References (20)

1. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. Br Med J 1994; 359: 453-457.
2. Kukovetz WR, Poch G, Holzmann S. In Cyclic nucleotides and relaxation of vascular smooth muscle. Vasodilatation, eds. Vanhoutte PM, Leuzen I. 1981; 339-353. New York: Raven Press.
3. Graves J, Poston L. β-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993; 108: 631-637.
4. Gray DW, Marhall I. Novel signal transduction pathway mediating endothelium-dependant β-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992; 107: 684-690.
5. Parent R, Al-Obaidi M, Lavalle'e M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 1993; 73: 241-251.
6. G-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxyaminoadenosine or salbutamol in conscious rats. Br J Pharmacol 1991; 103: 1725-1732.
7. Moncada S, Rees DD, Scultz R, Palmer RMJ. Development and mechanisms of a specific supersensitivity to nitovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991; 88: 2166-2170.
8. Konishi M, Su C. Role of the endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983; 5: 881-886.
9. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25: 918-923.
10. Lembo G, Iaccarino G, Barbato E, et al. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. J Clin Invest 1997; 100: 2007-2014.
11. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Decreased vasodilator response to isoprotenerol during nitric oxide inhibition in humans. Hypertension 1997; 30: 918-921.
12. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997; 95: 2293-2297.
13. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-H1149.
14. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in-vivo. Circulation 1995; 91: 1314-1319.
15. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol 1994; 38: 311-315.
16. Howell RE, Albelda SM, Daise ML, Levine EM. Characterisation of β-adrenergic receptors in cultured human and bovine endothelial cells. J Appl Physiol 1988; 65: 1251-1257.
17. Heuze-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol 1992; 220: 161-171.
18. Rebich S, Devine JO, Armstead WM. Role of nitric oxide and cAMP in β-adrenoceptor-induced pial artery vasodilatation. Am J Physiol 1995; 268: H1071-H1076.
19. Graier WF, Groschner K, Schmidt K, Kukovetz WR. Increases in endothelial cyclic AMP level amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem J 1992; 288: 345-349.
20. 2+ release from internal stores in neuronal cell line is enhanced by cyclic AMP. Eur J Pharmacol 1992; 227: 89-93.